Dr. Cantor is the Chief Scientific Officer and Chairman of Sequenom (NASD:SQNM), and a member of the National Academy of Sciences. He was previously the chair and professor of the department of biomedical engineering and biophysics, and director of the Center for Advanced Biotechnology, at Boston University. Prior to this, Dr. Cantor held faculty positions at Columbia University. He was also director of the Human Genome Center Project of the Department of Energy at Lawrence Berkeley Laboratory. Dr. Cantor is a consultant to more than 16 biotech firms, has published more than 325 peer reviewed articles and has been granted 26 U.S. patents.

Company Profile (History) | Senior Management Team | Board of Directors | Scientific Advisory Board
Robert F. Johnston - Chairman of the Board | Charles R. Cantor, Ph.D. | Myra Williams, Ph.D. | Arnold Levine, Ph.D. | Bijan Almassian, Ph.D.